StockData
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. (IDYA) stock

IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/307% below fair value
$26.49−0.91 (-3.32%)

Close on Nov 18, 2026Market cap $2.56BP/E –Yield –

IDEAYA Biosciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

IDEAYA Biosciences's revenue for the twelve months ending Jun 30, 2026 was $234.13M. For fiscal 2025 it was $218.71M, up 3024.4% from the year before. The highest annual figure on record is $218.71M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$218.71M+3024.4%
FY2024Dec 31, 2024$7.00M-70.1%
FY2023Dec 31, 2023$23.39M-54.1%
FY2022Dec 31, 2022$50.93M+82.3%
FY2021Dec 31, 2021$27.94M+43.0%
FY2020Dec 31, 2020$19.54M–
FY2019Dec 31, 2019$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$8.86M+26.5%
Q1 FY2026Mar 31, 2026$6.56M–
Q4 FY2025Dec 31, 2025$10.88M–
Q3 FY2025Sep 30, 2025$207.83M–
Q4 FY2024Dec 31, 2024$7.00M+78.5%
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$0-100.0%
Q1 FY2024Mar 31, 2024$0-100.0%
Q4 FY2023Dec 31, 2023$3.92M-2.5%
Q3 FY2023Sep 30, 2023$8.04M-72.9%
Q2 FY2023Jun 30, 2023$3.54M-39.4%
Q1 FY2023Mar 31, 2023$7.88M-30.6%
Q4 FY2022Dec 31, 2022$4.02M+35.8%
Q3 FY2022Sep 30, 2022$29.70M+230.9%
Q2 FY2022Jun 30, 2022$5.85M-33.2%
Q1 FY2022Mar 31, 2022$11.36M+56.7%
Q4 FY2021Dec 31, 2021$2.96M-72.0%
Q3 FY2021Sep 30, 2021$8.98M+0.1%
Q2 FY2021Jun 30, 2021$8.76M–
Q1 FY2021Mar 31, 2021$7.25M–
Q4 FY2020Dec 31, 2020$10.57M–
Q3 FY2020Sep 30, 2020$8.97M–

More IDEAYA Biosciences figures

See a number that looks wrong?